Safety of umeclidinium/vilanterol in Chinese patients in a real-world setting:a prospective,multicenter,single-arm,observational study

Objective To evaluate the safety of umeclidinium/vilanterol in Chinese participants in a real-world setting.Methods This was a 24-week,prospective,multicenter,single-arm,observational study that enrolled participants treated with umeclidinium/vilanterol in real-world settings from 14 sites in China from 14 December 2020 to 30 January 2022.